215 related articles for article (PubMed ID: 32126306)
1. Photodynamic therapy in combination with surgery for the treatment of an extensive squamous cell carcinoma in situ - A case report.
Salvio AG; Stringasci MD; Barreto Requena M; Bagnato VS
Photodiagnosis Photodyn Ther; 2020 Jun; 30():101700. PubMed ID: 32126306
[TBL] [Abstract][Full Text] [Related]
2. Methyl-aminolevulinate photodynamic therapy for the treatment of actinic keratoses and non-melanoma skin cancers: a retrospective analysis of response in 462 patients.
Fai D; Arpaia N; Romano I; Vestita M; Cassano N; Vena GA
G Ital Dermatol Venereol; 2009 Jun; 144(3):281-5. PubMed ID: 19528909
[TBL] [Abstract][Full Text] [Related]
3. Long-term recurrence of nonmelanoma skin cancer after topical methylaminolevulinate photodynamic therapy in a dermato-oncology department.
Cabete J; Rafael M; Cravo M; Moura C; Sachse F; Pecegueiro M
An Bras Dermatol; 2015; 90(6):846-50. PubMed ID: 26734866
[TBL] [Abstract][Full Text] [Related]
4. Successful treatment for multiple Bowen's disease using photodynamic therapy: A case report.
Wu MF; Lv T; Wang HW
Photodiagnosis Photodyn Ther; 2020 Jun; 30():101783. PubMed ID: 32330610
[TBL] [Abstract][Full Text] [Related]
5. Methylaminolaevulinate-based photodynamic therapy of Bowen's disease and squamous cell carcinoma.
Calzavara-Pinton PG; Venturini M; Sala R; Capezzera R; Parrinello G; Specchia C; Zane C
Br J Dermatol; 2008 Jul; 159(1):137-44. PubMed ID: 18489606
[TBL] [Abstract][Full Text] [Related]
6. Aminolevulinic acid photodynamic therapy for skin cancers.
Blume JE; Oseroff AR
Dermatol Clin; 2007 Jan; 25(1):5-14. PubMed ID: 17126737
[TBL] [Abstract][Full Text] [Related]
7. Interventions for cutaneous Bowen's disease.
Bath-Hextall FJ; Matin RN; Wilkinson D; Leonardi-Bee J
Cochrane Database Syst Rev; 2013 Jun; 2013(6):CD007281. PubMed ID: 23794286
[TBL] [Abstract][Full Text] [Related]
8. [Topical photodynamic therapy in basal and squamous cell carcinoma and penile Bowen's disease with 20% aminolevulinic acid, and exposure to red light and infrared light].
Harth Y; Hirshovitz B
Harefuah; 1998 Apr; 134(8):602-5, 672, 671. PubMed ID: 10911421
[TBL] [Abstract][Full Text] [Related]
9. Methyl aminolevulinate-PDT for actinic keratoses and superficial nonmelanoma skin cancers.
Ortiz-Policarpio B; Lui H
Skin Therapy Lett; 2009; 14(6):1-3. PubMed ID: 19609473
[TBL] [Abstract][Full Text] [Related]
10. The France-PDT study: a national prospective observational cohort survey on the use of methyl-aminolevulinate photodynamic therapy in France, with up to 6-month follow-up.
Farhi D; Bedane C; Savary J; Basset-Seguin N
Eur J Dermatol; 2013; 23(1):68-76. PubMed ID: 23400280
[TBL] [Abstract][Full Text] [Related]
11. Methyl aminolaevulinate-photodynamic therapy for actinic keratoses, squamous cell carcinoma in situ and superficial basal cell carcinoma employing a square wave intense pulsed light device for photoactivation.
Downs AM; Bower CB; Oliver DA; Stone CA
Br J Dermatol; 2009 Jul; 161(1):189-90. PubMed ID: 19416229
[No Abstract] [Full Text] [Related]
12. Photodynamic therapy for nonmelanoma skin cancers. Current review and update.
Zeitouni NC; Oseroff AR; Shieh S
Mol Immunol; 2003 Jul; 39(17-18):1133-6. PubMed ID: 12835091
[TBL] [Abstract][Full Text] [Related]
13. Methyl aminolevulinate-based photodynamic therapy of Bowen´s disease: Observational study of 21 lesions.
Gómez C; Cobos M; Alberdi E
Photodiagnosis Photodyn Ther; 2019 Jun; 26():295-299. PubMed ID: 30986539
[TBL] [Abstract][Full Text] [Related]
14. Photodynamic therapy for Bowen's Disease (squamous cell carcinoma in situ) current review and update.
O'Connell KA; Okhovat JP; Zeitouni NC
Photodiagnosis Photodyn Ther; 2018 Dec; 24():109-114. PubMed ID: 30240928
[TBL] [Abstract][Full Text] [Related]
15. A cost analysis of photodynamic therapy with methyl aminolevulinate and imiquimod compared with conventional surgery for the treatment of superficial basal cell carcinoma and Bowen's disease of the lower extremities.
Aguilar M; de Troya M; Martin L; Benítez N; González M
J Eur Acad Dermatol Venereol; 2010 Dec; 24(12):1431-6. PubMed ID: 20456549
[TBL] [Abstract][Full Text] [Related]
16. Fractionated aminolevulinic acid-photodynamic therapy provides additional evidence for the use of PDT for non-melanoma skin cancer.
de Haas ER; de Vijlder HC; Sterenborg HJ; Neumann HA; Robinson DJ
J Eur Acad Dermatol Venereol; 2008 Apr; 22(4):426-30. PubMed ID: 18031503
[TBL] [Abstract][Full Text] [Related]
17. Photodynamic therapy for non-melanoma skin cancer.
Fien SM; Oseroff AR
J Natl Compr Canc Netw; 2007 May; 5(5):531-40. PubMed ID: 17509255
[TBL] [Abstract][Full Text] [Related]
18. Modified topical photodynamic therapy of superficial skin tumors, utilizing aminolevulinic acid, penetration enhancers, red light, and hyperthermia.
Harth Y; Hirshowitz B; Kaplan B
Dermatol Surg; 1998 Jul; 24(7):723-6. PubMed ID: 9693665
[TBL] [Abstract][Full Text] [Related]
19. Is the pain of topical photodynamic therapy with methyl aminolevulinate any different from that with 5-aminolaevulinic acid?
Ibbotson SH; Valentine R; Hearn R
Photodermatol Photoimmunol Photomed; 2012 Oct; 28(5):272-3. PubMed ID: 22971196
[TBL] [Abstract][Full Text] [Related]
20. Photodynamic therapy in the treatment of extensive Bowen's disease.
López N; Meyer-Gonzalez T; Herrera-Acosta E; Bosch R; Castillo R; Herrera E
J Dermatolog Treat; 2012 Dec; 23(6):428-30. PubMed ID: 21787214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]